Breast cancer
Effect of Intravenous Lignocaine, Peri-tumoral Lignocaine or Standard Care on Biomarkers in Breast Cancer Surgery Patients
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyStudy of how care is given
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
All India Institute of Medical Sciences (AIIMS), BhopalBhopalDirections ↗
Registry summary (technical)
Effect of Intravenous Lignocaine, Peri-tumoral Lignocaine or Standard Care on Pro-metastatic Biomarkers in Breast Cancer Surgery Patients: A Triple-arm Randomized Controlled Trial - NIL
Sponsor: Dr Zainab Ahmad
CTRI/2025/03/081983 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 14 Sep 2026 · read by us 5 Nov 2026